ADVANCED GASTRIC ADENOCARCINOMA
Clinical trials for ADVANCED GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a stronger chemo cocktail extend life for stomach cancer patients?
Disease control Recruiting nowThis study compares two chemotherapy combinations for people with advanced stomach, esophageal, or gastroesophageal junction cancer that cannot be removed by surgery or has spread. About 382 participants will receive either the standard FOLFOX chemo (with or without the immunothe…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
New drug combo shows promise in advanced stomach cancer trial
Disease control Recruiting nowThis study is for people with advanced stomach or esophageal cancer that has spread. It tests whether adding the immunotherapy drug nivolumab to the usual two-drug treatment (paclitaxel and ramucirumab) helps control the cancer longer. About 224 participants will be randomly assi…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
New combo attack on stomach cancer shows early promise
Disease control Recruiting nowThis early-phase trial tests two drugs, pembrolizumab and lenvatinib, in about 15 people with advanced stomach or gastroesophageal cancer that has spread or can't be surgically removed. Pembrolizumab helps the immune system fight cancer, while lenvatinib blocks enzymes that help …
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
New drug combo shows promise in stomach cancer trial
Disease control Recruiting nowThis study tests whether adding the drug ivonescimab to standard chemotherapy helps shrink tumors in people with advanced stomach or esophageal cancer. About 88 participants will receive treatment every two weeks. The main goal is to see if more patients respond to the combinatio…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Engineered immune cells take on stomach cancer in new trial
Disease control Recruiting nowThis study tests a new treatment for advanced stomach or gastroesophageal junction cancer that has spread or cannot be removed by surgery. The treatment uses specially engineered immune cells (CAR-NK cells) from donated cord blood that target two proteins on cancer cells. Up to 3…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 22, 2026 13:51 UTC